News Releases

Pestmaster Franchisee Paul Alley Announces Expansion of ContraPest® Deployment in Animal Sanctuaries

FLAGSTAFF, Ariz., March 7, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, and Pestmaster Services (Pestmaster),  a pest control industry leader and an authority on Integrated Pest Management (IPM) solutions, announced today that deployment of ContraPest® has has been expanded into additional animal sanctuaries following the successful deployment at an initial facility in upstate New York. 

SenesTech, Inc. has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product, ContraPest(R), is marketed for use initially in controlling rat infestations. (PRNewsfoto/SenesTech, Inc.) (PRNewsfoto/SenesTech, Inc.)

Due to the sensitive nature of animal sanctuaries, most lethal rodent control methods are forbidden, thus allowing rodent populations to thrive. Paul Alley, the President of PestMaster servicing New York, made the decision to utilize ContraPest® for his animal sanctuary client to gain control of rodent populations and reverse the problems that the sanctuary was encountering such as property damage, animal feed loss and contamination. After implementing ContraPest, Paul was able to achieve a level of rodent control that the sanctuary had yet to experience by creating a sustainable, long-term rodent program with which his clients were pleased. This led to the expansion of using ContraPest at other animal sanctuaries in the region, who were in desperate need of a non-lethal product to control their rodent infestation.

"With the growing concerns of secondary poisioning of non-target species, fighting rodent infestations can be difficult, especially at sensitive locations where animals are housed. ContraPest provides a tool that can be used at animal sanctuaries where lethal methods of control are not an option," said Paul Alley. "ContraPest is a good addition to have in your IPM toolbox and it's nice to have that relationship with SenesTech."

"Animal sanctuaries and zoos are particularly dear to SenesTech, not just because ContraPest is such an obvious tool, but also because of our overall mission and corporate social responsibility," said Dr. Loretta Mayer, CEO and co-founder of SenesTech.

About SenesTech 

SenesTech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction.

ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.

We believe ContraPest® will establish a new paradigm in rodent control, resulting in a decreased reliance on lethal options. For more information visit the SenesTech website at

Safe Harbor Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. Forward looking statements include, but are not limited to, our expectation regarding sales commitments, our expectation regarding the conversion of sales commitments and programs to revenue, our belief that our product is more humane, less harmful to the environment and more effective than traditional methods, and our belief that ContraPest will establish a new paradigm in rodent control without environmental effects of rodenticides.  All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.


Investor: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143


SOURCE SenesTech, Inc.